[go: up one dir, main page]

MA31244B1 - Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs - Google Patents

Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs

Info

Publication number
MA31244B1
MA31244B1 MA32210A MA32210A MA31244B1 MA 31244 B1 MA31244 B1 MA 31244B1 MA 32210 A MA32210 A MA 32210A MA 32210 A MA32210 A MA 32210A MA 31244 B1 MA31244 B1 MA 31244B1
Authority
MA
Morocco
Prior art keywords
amorphous
solution containing
carriers
carboxamide derivatives
containing pyrazole
Prior art date
Application number
MA32210A
Other languages
Arabic (ar)
English (en)
Inventor
Jean Alie
Michel Bauer
Jérôme Menegotto
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MA31244B1 publication Critical patent/MA31244B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La présente invention se rapporte à un dérivé de pyrazole-3-carboxamide sous forme amorphe, à une solution solide amorphe le contenant, et plus généralement aux compositions pharmaceutiques le contenant.
MA32210A 2007-02-23 2009-09-10 Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs MA31244B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0701377A FR2913018A1 (fr) 2007-02-23 2007-02-23 Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs
PCT/FR2008/000216 WO2008129157A2 (fr) 2007-02-23 2008-02-20 Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs

Publications (1)

Publication Number Publication Date
MA31244B1 true MA31244B1 (fr) 2010-03-01

Family

ID=38561793

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32210A MA31244B1 (fr) 2007-02-23 2009-09-10 Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs

Country Status (20)

Country Link
US (1) US20100076023A1 (fr)
EP (1) EP2132182A2 (fr)
JP (1) JP2010519246A (fr)
KR (1) KR20090113305A (fr)
CN (1) CN101641333A (fr)
AR (1) AR065410A1 (fr)
AU (1) AU2008240507A1 (fr)
BR (1) BRPI0807575A2 (fr)
CA (1) CA2678801A1 (fr)
CL (1) CL2008000550A1 (fr)
CO (1) CO6210812A2 (fr)
EA (1) EA200970792A1 (fr)
FR (1) FR2913018A1 (fr)
IL (1) IL200370A0 (fr)
MA (1) MA31244B1 (fr)
MX (1) MX2009008991A (fr)
PE (1) PE20081778A1 (fr)
TW (1) TW200846339A (fr)
UY (1) UY30937A1 (fr)
WO (1) WO2008129157A2 (fr)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2761266B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
FR2873372B1 (fr) * 2004-07-22 2006-09-08 Sanofi Synthelabo Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide
EP1844017A1 (fr) * 2005-01-06 2007-10-17 Cadila Healthcare Ltd. Forme amorphe et trois formes cristallines de chlorhydrate de rimonabant
AR052660A1 (es) * 2005-01-21 2007-03-28 Astex Therapeutics Ltd Derivados de pirazol para inhibir la cdk's y gsk's
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
EP1816125A1 (fr) * 2006-02-02 2007-08-08 Ranbaxy Laboratories, Ltd. Formes cristallines d'un antagoniste du récepteur cannabinoïde CB1 et son procédé de préparation
WO2007103711A2 (fr) * 2006-03-01 2007-09-13 Dr. Reddy's Laboratories Ltd. Formes polymorphes du rimonabant
US8431609B2 (en) * 2007-02-19 2013-04-30 Darmesh Mahendrabhai Shah Process for preparation of pyrazole derivatives

Also Published As

Publication number Publication date
WO2008129157A3 (fr) 2008-12-31
KR20090113305A (ko) 2009-10-29
IL200370A0 (en) 2010-04-29
AU2008240507A1 (en) 2008-10-30
BRPI0807575A2 (pt) 2014-07-01
WO2008129157A2 (fr) 2008-10-30
WO2008129157A4 (fr) 2009-03-05
CL2008000550A1 (es) 2008-07-04
CA2678801A1 (fr) 2008-10-30
AR065410A1 (es) 2009-06-03
US20100076023A1 (en) 2010-03-25
EP2132182A2 (fr) 2009-12-16
CO6210812A2 (es) 2010-10-20
MX2009008991A (es) 2009-09-03
UY30937A1 (es) 2008-09-30
PE20081778A1 (es) 2009-01-01
EA200970792A1 (ru) 2010-04-30
CN101641333A (zh) 2010-02-03
FR2913018A1 (fr) 2008-08-29
TW200846339A (en) 2008-12-01
JP2010519246A (ja) 2010-06-03

Similar Documents

Publication Publication Date Title
ATE447568T1 (de) Neue pyrinderivate
JO3408B1 (ar) مركبات بترين سلفون اميد ثيازول و أوكسازول
BRPI0922364A2 (pt) Composto, composição farmacêutica e uso de um composto
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
MY154909A (en) Novel thiophene derivatives
MX2009004766A (es) Derivados de espiroindolinona.
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
MX2010001754A (es) Derivados de azepina como inhibidores de gamma secretasa.
WO2009042114A3 (fr) Dérivés de phénazine et leurs utilisations
TW200716119A (en) A solid pharmaceutical dosage formulation
CR11819A (es) Compuestos de isoindolina 5-sustituidos
TW200700406A (en) Novel thiophene derivatives
GEP20125702B (en) Benzimidazole derivatives
TW200708511A (en) Novel thiophene derivatives
PT2310356E (pt) Derivados de adamantildiamida e a sua utilização
TW200942524A (en) Novel aminomethyl benzene derivatives
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
PA8792401A1 (es) Fenilendiaminas
CL2007000595A1 (es) Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras.
MX2010009927A (es) Derivados de espiroindolinona.
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
UY30801A1 (es) Compuestos calciliticos
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments